MedTrace Logo

Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer

NCT00103155 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Ultrasound-guided radiofrequency ablation may be effective treatment for thyroid cancer.

PURPOSE: This phase I trial is studying the side effects of radiofrequency ablation in treating patients who are undergoing surgery for thyroid cancer.

Conditions

Interventions

PROCEDURE

conventional surgery

PROCEDURE

radiofrequency ablation

Sponsors & Collaborators

Principal Investigators

  • Electron Kebebew, MD · University of California, San Francisco

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00103155 on ClinicalTrials.gov